http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002147494-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-09083
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0009
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
filingDate 2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eada2ca9fc284e77aa2d21d731736cc6
publicationDate 2002-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2002147494-A1
titleOfInvention High strength member for intracorporeal use
abstract This invention is directed to an intracorporeal device formed of a high strength Co—Ni—Cr alloy and is particularly suitable for forming a composite product with a pseudoelastic member formed of NiTi alloy. Suitable intracorporeal products include guidewires and stents. The high strength alloy consists essentially of about 28 to about 65% cobalt, about 2 to about 40% nickel, about 5 to about 35% chromium, up to about 12% molybdenum, up to about 20% tungsten, up to about 20% iron and the balance inconsequential amounts of impurities and other alloying constituents, with a preferred alloy composition including about 30 to about 45% cobalt, about 25 to about 37% nickel, about 15 to about 25% chromium and about 5 to about 15% molybdenum. Intravascular devices such as guidewires, stents and the like can be formed of this high strength Co—Ni—Cr alloy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104644296-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011054592-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019147982-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010140105-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005119727-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6999934-B2
priorityDate 1994-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5217483-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5891193-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5824077-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4582118-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5064435-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411130

Total number of triples: 32.